Stock listing

ZVRA Stock Price, News, Filings & Events — Zevra Therapeutics, Inc.

Selected listing: ZVRA · BOATS · USD · US

This page tracks Zevra Therapeutics, Inc.'s ZVRA:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ZVRA:BOATS. ZVRA:BOATS is the stock-level entry point for investors researching Zevra Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Zevra Therapeutics, Inc. is a public company traded under the ticker ZVRA in the American market. The company has a market capitalization of approximately $789.2 million. Zevra focuses on developing innovative therapies to address unmet medical needs.

ZVRA:BOATSUSDUSUpdated August 21, 2026
Zevra Therapeutics, Inc. logo
Ticker
ZVRA:BOATS
Asset type
Stock
Market cap
$704.9M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BOATS
Currency
USD

Zevra Therapeutics, Inc. ZVRA:BOATS stock context

This page tracks Zevra Therapeutics, Inc.'s ZVRA:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ZVRA:BOATS. ZVRA:BOATS is the stock-level entry point for investors researching Zevra Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Zevra Therapeutics, Inc. is a public company traded under the ticker ZVRA in the American market. The company has a market capitalization of approximately $789.2 million. Zevra focuses on developing innovative therapies to address unmet medical needs.

Latest news from Zevra Therapeutics, Inc.

All Zevra Therapeutics, Inc. news →

Research Zevra Therapeutics, Inc.

Alternate listings